Drug · DIN 02492407
ZOPICLONE TABLETS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 28, 2023; first marketed September 29, 2020.
- Drug Identification Number (DIN)
- 02492407
- Company (DIN owner)
- Nora Pharma Inc.Varennes, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Zopiclone N05CF01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZOPICLONE | 3.75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2022: NOC 28420Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership. Administrative: Licensing Agreement Between Two Companies
- August 27, 2021: NOC 26535Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership
- September 20, 2019: NOC 22679Supplement to an Abbreviated New Drug Submission (SANDS) · Licensing agreement between two companies
Other DINs named ZOPICLONE TABLETS
- DIN 02425874 · Cancelled Post Market
- DIN 02425882 · Cancelled Post Market